Compare GOOS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOOS | AMPH |
|---|---|---|
| Founded | 1957 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 931.6M | 885.4M |
| IPO Year | 2016 | 2005 |
| Metric | GOOS | AMPH |
|---|---|---|
| Price | $8.69 | $20.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $12.60 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 798.3K | 444.5K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $12.21 | $6.90 |
| Revenue Next Year | $5.16 | $4.64 |
| P/E Ratio | $75.22 | ★ $24.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.56 | $16.65 |
| 52 Week High | $14.69 | $31.26 |
| Indicator | GOOS | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 52.27 |
| Support Level | N/A | $18.36 |
| Resistance Level | $10.42 | $20.29 |
| Average True Range (ATR) | 0.31 | 0.77 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 15.31 | 32.84 |
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.